Patients with epilepsy often seek CAM therapies—with or without the recommendations or explicit approval of their neurologist.
Epilepsy and Seizure
Repeated brain MRI scans show four small gray matter lesions. What’s in your differential?
Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
How does DBS differ from other methods of neuromodulation? This question and more in this Q&A with Dr Robert Gross, a neurosurgical primary investigator in an important trial.
Results of this Swedish study may help guide decisions about monitoring and induction of labor.
Guidelines from the American Academy of Neurology now cover the use of third-generation antiepileptic drugs for patients with new-onset focal or generalized epilepsy.
After a teenager spends 2 months in the ICU with refractory seizures, his family requests a trial of cannabidiol oil.
New research found over a quarter of children with treatment-refractory epilepsy sustained treatment response to CBD over four years.
A middle-aged man explains that his seizures occur almost daily, and he suggests that either diazepam or the recently approved cannabis (CBD) medication would help control them.
Because automobiles are such an important aspect of our culture, driving restriction is an enormous problem for many of the 65 million individuals with epilepsy worldwide and their families.